GLOW blend
Healing with a skin glow-up — tissue repair + collagen
2.400.000 ₫
Vial-by-vial breakdown
Delivery method:
Single vial blend
GLOW pen
The Wolverine repair backbone (BPC-157 + TB-500) layered with GHK-Cu — a copper-binding tripeptide that drives skin regeneration, collagen synthesis and antioxidant gene expression. BPC-157 and TB-500 do the deep structural work: tendon, ligament and muscle repair through fibroblast activation, stem-cell recruitment and angiogenesis. GHK-Cu adds the surface and longevity layer — clinical work shows it lifts collagen synthesis by ~70%, modulates roughly a third of the human genome toward repair phenotypes, and visibly improves skin firmness, thickness and tone in human trials. The result is a 'whole-envelope' protocol: internal soft-tissue healing plus skin and connective-tissue rejuvenation in one daily injection. Most users run it for 6–8 weeks around recovery, post-procedure healing, or as a structured anti-aging block.
Dosage
Start 0.25mg BPC + 0.25mg TB + 1mg GHK-Cu daily; after 1 week double to 0.5mg + 0.5mg + 2.5mg
Duration of effect
Daily dosing; skin benefits build over weeks (plasma half-life: ~4-6 hours)
See full half-life table →Key Features
- Tissue repair
- Skin glow-up
- Collagen boost
- Full rejuvenation
Includes key details, half-life data, usage notes and research sources.
Usage Instructions
Subcutaneous or intramuscular injection. May be split into multiple smaller doses throughout the day. Consult a specialist for personalized protocols.
Research Highlights
- Backed by scientific research
- Manufactured to pharmaceutical standards
- Used in clinical research settings
- Established safety profile
Safety Information
- •Consult your healthcare provider before use
- •Not intended for pregnant or nursing women
- •Store properly according to instructions
- •Report any adverse effects to your healthcare provider
Source: Cosmetics - ResearchGate
Clinical Research
GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes, increasing collagen synthesis by 70%.
Read full studyAdditional Research
Source: Pickart & Vasquez-Soltero, BioMed Research International (2015)
Peer-reviewed analysis of GHK-Cu's effects on human skin shows the peptide modulates over 4,000 human genes — most reset toward a younger transcriptional profile — driving collagen, elastin and glycosaminoglycan synthesis.
Read full studyHuman Clinical Trials
- GHK-Cu facial wrinkle studyJournal of Aging Science · 2016
Randomised double-blind facial study in 40 women: topical GHK-Cu improved wrinkle parameters versus the vehicle cream.
Small topical skin study, not an injectable trial.
Read the trial40participants - Thymosin β4 first-in-human studyAnnals of the New York Academy of Sciences · 2010
Randomised placebo-controlled single and multiple dose study in healthy volunteers, covering safety and blood levels.
Safety only, and it studied the full-length peptide rather than the shorter fragment sold online.
Read the trial40participants